Jatenzo (testosterone undecanoate) NDC 69087-158

NDC codes

FDA NDC Directory

Product NDC (as listed)69087-158Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69087-0158Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69087-158-12	69087015812	12 BOTTLE, PLASTIC in 1 BOX (69087-158-12) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTICMarketed from Aug 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Jatenzo
Generic name (nonproprietary): testosterone undecanoate
Active ingredients: Testosterone undecanoate — 158 mg/1
Dosage form: Capsule, Liquid filled
Route: Oral
Labeler: TOLMAR Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 206089
Marketing start: Aug 1, 2019
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Androgen Receptor Agonists (Mechanism)Androstanes (Chemical structure)
Identifiers: Product ID 69087-158_9db3c914-8c33-4b65-86d3-5dc5c775b00bSPL ID 9db3c914-8c33-4b65-86d3-5dc5c775b00bSPL set ID ed7b5d41-7475-4c10-99b9-b62b3434ae60RxCUI 2121766, 2121768, 2121770, 2121776, 2201640, 2201642UNII H16A5VCT9C
Pharmacologic class: Androgen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469087015812 followed by a unit qualifier and the quantity

Package 69087-0158-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 30, 2025.

Indications (excerpt from the label)

JATENZO (testosterone undecanoate) is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteiniz…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 206089

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 206089
Product	Strength	Form · route	Labeler	Product NDC
Jatenzotestosterone undecanoate	Testosterone undecanoate 198 mg/1	Capsule, Liquid filledOral	TOLMAR Inc.	69087-198
Jatenzotestosterone undecanoate	Testosterone undecanoate 237 mg/1	Capsule, Liquid filledOral	TOLMAR Inc.	69087-237